Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor
April 2012
in “Daehan namseong gwahag hoeji”
TLDR Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.
The 2012 study involving 354 patients with Benign Prostatic Hyperplasia (BPH) compared the efficacy of finasteride and dutasteride, both 5-alpha reductase inhibitors. The results showed that dutasteride was more effective in reducing total prostate volume (TPV) by 28.2% and Prostate-Specific Antigen (PSA) levels by 43.6%, compared to finasteride's reduction of TPV by 20.5% and PSA by 39.2%. However, both drugs had similar side effects and there were no significant differences in quality of life score, maximal flow rate increment, or post-void residual urine reduction. The study concluded that more large-scale studies were needed to definitively compare the two drugs.
View this study on wjmh.org →
Cited in this study
research Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor
Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.
research Comparison of clinical trials with finasteride and dutasteride.
research The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia
Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.
research The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia
Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.
Related
research Comparative Effect of Finasteride and Dutasteride on Chromogranin A Levels
research The effects of lovastatin on conventional medical treatment of lower urinary tract symptoms with finasteride
Lovastatin doesn't improve lower urinary tract symptoms treatment.
research Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.